(A) Boxplots showing the number of genes expressed across the cells from "co-expressing" endocrine, endocrine and exocrine cell types using two different thresholds (RPKM≥1 and RPKM≥5). The "coexpressing" cells have a larger number of genes expressed compared to the other endocrine cells, in line with the potential sorting of cell doublets. (B) Boxplots showing the number of genes expressed across the cells from unclassified endocrine, endocrine and exocrine cell types using two different thresholds (RPKM≥1 and RPKM≥5). The unclassified endocrine cells express very few genes, which could have resulted from failures to accurately amplify the cellular RNA or that only parts of a cell was deposited into these wells of the plate during FACS distribution. Both the "co-expressing" and unclassified endocrine cells were excluded from the analyses of the paper. 
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SUPPLEMENTAL TABLES
(supplied as Excel file: Supplemental Table 4 .xlsx) Figure 6 . Lists of the genes identified as differentially expressed between healthy individuals and type 2 diabetes.
(supplied as Excel file: Supplemental Table 6 .xlsx) Table S7 . Gene set enrichment analysis (GSEA). Related to Figure 6 . Detailed results from the Gene Set Enrichment Analysis (GSEA) performed on each cell type that are listed in separate sheets in the Excel file.
(supplied as Excel file: Supplemental Table 7 .xlsx)
SUPPLEMENTAL EXPERIMENTAL PROCEDURES Human tissue collection
Human primary islets from 6 healthy and 4 type 2 diabetic diseased donors were purchased from Prodo Laboratories Inc (Irvine, CA, USA) providing islet isolated from donor pancreases obtained with research consent from Organ Procurement Organizations (OPOs) (Kühtreiber et al., 2010) and kept in Prodo Islet Media Standard (PIM(S)) complete. The use and storage of human islets and tissue samples was performed in compliance with the Declaration of Helsinki, ICH/Good Clinical Practice and was approved by the independent Regional Ethics Committee (Gothenburg, Sweden).
Dissociation of islet cells
Human islet samples (85-95% pure) were cultured for 4 days in a 37°C incubator with 5% CO2 in PIM complete media to recover after arrival. Media was changed every second day. For preparation of a single-cell suspension, 300 islets were identified using a microscope and handpicked to a tube containing fresh culture media. Islets were allowed to sediment on ice for 5 minutes or gently centrifuged if necessary. Media was removed carefully and 1 mL pre-warmed TrypLE Express (Life Technologies, Darmstadt, Germany) was added. The islets were incubated for 5 minutes in a water bath at 37°C and triturated by resuspending 4-5 times during incubation. Remaining cell aggregates were removed with a 40 µm filter. Dissociated islet cells were washed once with culture media before FACS cell sorting.
FACS analysis of endocrine cells
Dissociated human islets cells were fixed with Fixation buffer I (BD Biosciences) at 37°C for 10 minutes. Cells were washed in DPBS without calcium and magnesium and permeabilized with Perm/Wash buffer (BD Biosciences). Cells were incubated over night at 4°C with primary antibodies, rabbit antichromogranin A (Abcam, Cambridge, UK), rat anti-c-peptide (Developmental Studies Hybridoma bank, The University of Iowa), rabbit anti-insulin (Cell Signaling technology, Beverly, MA), goat antisomatostatin (Santa Cruz) and mouse anti-glucagon (Abcam). For labeling of GLP1R, we have used BODYPI FL dye tagged GLP1R antagonist (Exendin 9-39) conjugate produced in a similar way as previously described (Montrose-Rafizadeh et al., 1997). After washing twice in BD Perm/wash buffer, cells were stained with secondary antibodies, donkey anti-rabbit alexa fluor 350, donkey anti-rat alexa fluor 488, donkey anti-goat alexa fluor 680 and donkey anti-mouse alexa fluor 594 (Invitrogen, Carlsbad, CA). Cells were washed twice in BD Perm/wash buffer and resuspended in DPBS without calcium and magnesium containing 2% FBS and 5mM EDTA. Analysis was performed on a BD LSR Fortessa.
FACS single-cell sorting
Dissociated primary islets cells were resuspended in 1mL DPBS without calcium and magnesium containing 2% FBS and 5mM EDTA (cell density should not exceed 1.5x10 6 /mL). Dead cells were stained with 7-AAD solution (BD Biosciences, San Jose, CA, USA) 5 minutes prior to fluorescenceactivated cell sorting (FACS) analysis and cell sorting using a BD FACS AriaII (BD Biosciences). FACS sorting was done using a ceramic nozzle with a size of 100 µm. Cell doublets were excluded by gating singlets on FSC-H and FSC-A. By using a single-cell discrimination mask viable individual islet cells were sorted and collected in FrameStar 384-well plates (4titude, Surrey, UK) containing 2,3 µL lysis buffer (0.4% TritonX100 (Sigma-Aldrich), 1 U RNase inhibitor (Clontech), 2,5 µM Smart dTVN30 oligos (Picelli et al., 2014) , 4mM dNTP (Thermo scientific, Waltham, MA USA), 0,1 µl (H1 donor) or 0,025 µl (all other 9 donors) of 1:40 000 dilution ERCC RNA spike-in mix (Ambion, Life Technologies)). Sample plates were kept at -80°C for future preparation into Smart-seq2 cDNA libraries.
Image-based validation of single-cell sorting
Cell-permeable Hoechst 33342 diluted 1:2000 (ThermoFisher, Invitrogen) and 5 µM of the vital dye calcein-AM (Invitrogen) were incubated with the cells for 30 minutes prior to FACS sorting (for details see FACS single-cell sorting, Experimental Procedures). Single cells, or in control wells hundreds of cells, were sorted into 384-well plates (Greiner Bio-One) and imaged using an ImageXpress automated fluorescence microscope fitted with a 4x S-fluor objective (3,2 pixels/µm). Well images were masked and segmented for cell counting using MetaXpress image analysis software (Molecular Devices, 5.3.0.1).
Glucose-stimulated insulin secretion (GSIS)
Glucose-stimulated insulin secretion (GSIS) of human islets from different donors was performed after 6-8 days in culture. Briefly, islets were washed in 2.8 mM Krebs Ringer phosphate hepes (KRH) buffer.
Five islets/well were transferred into a 96 well plate containing KRH buffer with 2.8 or 16.7 mM glucose. When testing the effect of a GLP1 receptor agonist, 10nM of exenatide (Ex4) (Bachem, Bubendorf, Switzerland) was added to KRH buffer containing 16.7mM glucose. Secreted insulin was measured in six replicates of each condition after 1 hour of incubation. Human Insulin ELISA (Mercodia AB, Uppsala, Sweden, article number 10-1113-01) was run according to manufacturer's protocol.
Immunohistochemistry
Histological staining was performed on 4 µm thick paraffin-embedded pancreatic tissue sections or isolated pancreatic islets using an IntelliPath FLX automated immunostainer (Biocare) as described previously (Walsh et al., 2014) . Primary antibodies, rabbit anti-secretogranin III (Atlas antibodies, Stockholm Sweden) diluted 1:350, mouse anti-glucagon (Sigma-Aldrich, Stockholm, Sweden) diluted 1:8000, guinea pig anti-insulin (Dako, Glostrup, Denmark) diluted 1:8000 and rabbit anti-GLP1R (Abcam), diluted 1:1000 was incubated for 1 hour following 1 or 2 steps of Polymer kit (Biocare Medical, Concord, CA, USA). Following anti-insulin labeling a secondary biotinylated donkey anti-Guinea Pig antibody (Jackson Laboratory, Bar Harbor, Maine, USA) was used. This was followed by 4+streptavidin horse radish peroxidase labeling for 10 minutes using 3-3'-diaminobenzidine as the chromogen (Biocare Medical). Stained sections were scanned and digitized at a magnification of ×20 with the use of the Carl Zeiss MIRAX slide scanner (Zeiss, Goettingen, Germany). For calculation of the region of interest and the area of staining the whole section from each donor was analyzed using BioPix Image software (BioPix, Gothenburg, Sweden).
Preparation and sequencing of single-cell RNA-sequencing libraries
Single-cell RNA-sequencing libraries were produced in half the reaction volumes compared to the Smartseq2 protocol previously described (Picelli et al., 2014) . The protocol was executed with either a liquid handling robot (Biomek FXP, Beckman Coulter) or by manual preparation. Adjustments to the original Smart-seq2 protocol were the following: cDNA was synthesized with Superscript II (Invitrogen) and 2µM TSO strand switch oligo and further amplified with ISPCR primers at a concentration of 0.08µM with KAPA High Fidelity Hot Start polymerase (Kapa Biosystems). The cDNA was purified using SeraMag magnetic SpeedBeads, carboxylate-modified (GE Healthcare Biosciences) in the presence of 19.5% PEG8000 at a 0.8:1 ratio beads:cDNA. The quality of the cDNA was assessed for random samples with an Agilent 2100 Bioanalyser and High Sensitivity DNA Chip (Agilent Technologies Inc.). Tn5 transposase directed tagmentation of 0.5-1 ng cDNA was performed with recombinant Tn5 in 10% PEG8000, 10mM TAPS-NaOH (pH 8.3), 5mM MgCl 2 (Picelli et al., 2014b) . The Tn5 enzyme was removed from the DNA with 0.04% SDS. Sequencing libraries were generated with Nextera XT Index kit v2 (Illumina Inc.) and KAPA High Fidelity amplification (Kapa Biosystems). Sequencing libraries were multiplexed with 192 cells in each and purified with Sera-Mag magnetic SpeedBeads, carboxylatemodified (GE Healthcare Biosciences) in the presence of 24% PEG8000 at 1:1 ratio beads:DNA. The quantity and quality of the sequencing libraries were analysed with an Agilent 2100 Bioanalyser and Qubit 2.0 Fluorometer (Invitrogen). Sequencing was carried out with an Illumina HiSeq 2000 generating 43 bp single-end reads.
Spearman's correlation (ρ) between single-cell and bulk expression data was computed for H3, H4, H6 and all T2D donors. Gene expression was averaged across single cells of the same individual and correlated against the corresponding whole-islet RNA-sequencing data. The correlations were computed using log 2 -transformed expression data. Only the genes with expression greater than zero either in bulk or in at least one single cell (Mean>0) were included in the calculations and in the graphs of Figure S4 . For the down-sampling procedure, Spearman's correlation coefficients were computed as described above, but using a subset of single cells for each individual. For each different number of cells tested, 200 iterations were performed in which cells were selected at random from each individual donor and correlated against the corresponding bulk data.
Identification of highly variable genes
Gene expression was ranked in descending order of variance across cells, while controlling for the relation between the expression magnitude and the variability arising from technical noise (Brennecke et al., 2013) . For this purpose, we used an in-house implementation of the method in R with the additional option of specifying the number of cells considered as outliers (winsorization). The winsorization parameter was set to 1 in order to prevent genes with extreme expression values in only one cell from being high in the ranking. Ranked lists of genes for the different cell groups analyzed are included in Table S1 .
Dimensionality reduction
The t-Distributed Stochastic Neighbor Embedding (t-SNE) method was employed to reduce the dimensions of the gene expression data and project the cells onto a two dimensional space (using the MATLAB implementation of t-SNE). The normalized expression values (log 2 RPKM) were used as input to the algorithm, while the number of principal components employed internally for the reduction was adjusted at every different run to retain the 60% of the total variability of the input data. The perplexity parameter was set to 50 when the number of cells exceeded 800, 30 for sample sizes up to 800 and 15 in the cases where the number of cells was less than 60.
Cell-type classification
The basic approach for the cell-type classification was the projection of cells with t-SNE onto the two dimensional space spanned by a set of genes adequate to capture the overall variability within the dataset. The assignment of the formed clusters to cell classes was obtained based on the expression levels of hormones or other known marker genes. The cell-type classification of all cells analyzed is included in Table S1 .
Differential expression analysis of the endocrine and exocrine cell types
For the differential expression analysis among the six major cell types (α, β, γ, δ, acinar and ductal cells) we performed one-way Analysis of variance (ANOVA) using the log 2 -transformed expression data from the five healthy male donors. The analysis was followed by multiple comparisons testing to further identify the cell types that displayed significant differences in their expression out of all the possible pairwise combinations. The reason for using only a subset from the available samples was to rule out any variations introduced in the data due to the sex and disease associated differences. Although such factors of variation could be modeled with a multifactorial design, the existence of small and unequal sample sizes arising from the different donors in each cell class would reduce the power of the statistical analysis. The criteria to include a gene in the differential analysis were based on the average magnitude (Mean log2RPKM >= 1 in at least 1 cell type) and variation of the expression in the cell types tested. To further reduce the risk of erroneously reporting individual donor differences as cell-type differential expression, we added two more requirements that every gene should meet in order to be tested. The first was that the expression detected in each cell type should come from cells belonging to at least two different individuals of the same cell type (Mean log2RPKM >= 1 in at least 2 donor groups of the same cell type).. Based on the second, the variation in at least two different donor groups of the same cell type should not be greater than the overall variation across the cell type. The Bonferroni adjustment was applied in order to correct for the multiple comparisons performed for each of the genes tested. Also, the Benjamini-Hochberg method was used to control the false discovery rate at significance level α=0.01. Similar results were obtained using a non-parametric test, but the results from the ANOVA differential expression analysis are summarized in Table S2 . The exact same procedure was repeated including the ε-cells from the five healthy male donors in order to identify cell type specific expression in this rare population. The non-parametric one-way ANOVA (Kruskal Wallis) test was additionally performed due to the difference in size of the samples being compared. The two tests gave similar results and we report the genes identified as up-regulated in ε-cells based on both analyses in Table S2 .
Single-molecule mRNA FISH mRNAs were visualized by single molecule FISH (smFISH) using the RNAscope Fluorescent Multiplex Kit (Advanced Cell Diagnostics, Inc.) according to the manufacturer's instructions. SmFISH stainings were performed on formalin-fixed, paraffin-embedded (FFPE) sections of pancreas from 4 healthy donors. The following RNAscope probes were used: Hs-GCG (ACD556741), hs-SST (ACD310591), hs-FAP (ACD411971) and hs-LEPR (ACD406371). Images were acquired on a Nikon A1R confocal microscope. The DAPI and probe signals within islets cells were manually appointed to either of four groups; i) negative for both hormone and gene of interest (GOI) ii) hormone positive and GOI negative, iii) hormone negative and GOI positive iv) hormone positive and GOI positive (Table S3) . Detailed information on cell counting and statistics per slide and donor are included in TableS3.
Differential expression analysis between the pancreatic stellate cells and endothelial cells
In order to identify the genes that are differentially expressed between the clusters consisting of pancreatic stellate and endothelial cells, the R/Bioconductor package SCDE (Kharchenko et al, 2014) was used. All genes expressed within the two cell classes were tested and the analysis was performed with the raw read counts as input. The grid of expression magnitude was set to 450 for increased sensitivity and the independent fit was selected for the error modeling. The results are summarized in Table S2 .
Comparison between single-cell and whole-islet RNA-sequencing cell-type enriched expression.
In order to assess the performance of previously used strategies in identifying cell type specific gene expression, we correlated the differentially expressed genes from the single-cell analysis with the cell type hormones or marker genes using the expression data published in Taneera et al. 2012. The genes were selected based on the magnitude of mean expression in each cell type. Spearman's correlation coefficients and p-values (adjusted) were calculated for the 25 strongest genes in each cell type with the corresponding hormone or marker gene: GCG for α, PPY for γ, SST for δ, REG1A for acinar and KRT19 for ductal top genes. Data for INS was not available in the study. The rank of each gene was obtained from sorting all the genes measured in the study in decreasing magnitude of correlation coefficient.
Analysis of heterogeneity in the cell types
To further explore the heterogeneity of the identified cell types, we analyzed their transcriptomes in isolation following the procedure as described above. The expression data of each cell type was ranked based on biological variability and using this as input the cells were projected onto two dimensions with the t-SNE. In all cases the obtained embedding was dominated by donor differences ( Figure S6 ). In order to correct for such effects that might confound biological differences, we used ComBat (Johnson et al, 2007) , more specifically a Python implementation of the ComBat function in R/Bioconductor package SVA. The method provides a robust adjustment even for small sample sizes as in the case of our dataset. We used the parametric empirical Bayesian framework, setting the adjustment variable to denote the donor individuals. The t-SNE dimensionality reduction was repeated with input the adjusted expression values. Following batch correction, the donor effect was completely removed from the resulting clusters in each cell type.
Differential expression analysis within the cell types
We performed differential expression analysis to identify the genes that are responsible for the resulting sub-clusters in each cell type: α, β and acinar cells. SCDE method was applied as previously described. The results obtained from the analysis in each cell type are summarized in Table S4 .
Relationship of BMI and gene expression in different cell types
The relationship between body mass index (BMI) and gene expression in each cell type was measured using rank correlation statistics. Spearman's ρ coefficients were calculated separately for each gene based on the log 2 -transformed expression values of the samples in each cell class. Since multiple tests were performed (one for every gene), the results were adjusted with the Benjamini-Hochberg method to control the false discovery rate at significance level α=0.01. Only the samples from the healthy male donors were used, since there is a positive correlation between BMI and sex in our donors (ρ=0.49). The lists containing genes with an absolute correlation coefficient with BMI greater than 0.5 are included in Table S5 . We also generated correlations per gene using all cells (not separated per cell type) from the same five male donors to simulate the correlations one would obtain in "whole-islet" analyses.
Differential expression analysis between cells from healthy and T2D donors
We compared the expression between the healthy and T2D samples in order to identify disease associated genes for the major cell types: α, β, γ, δ, acinar and ductal cells. For this purpose, we conducted nonparametric one-way Analysis of variance (Kruskal-Wallis test) using the samples from all donors in each cell type tested. The samples were divided into four groups based on the status (healthy or T2D) and sex, resulting into the four groups being compared: healthy male, healthy female, T2D male and T2D female. We also performed the analysis using a parametric multifactorial design: two-way Analysis of variance with the first factor indicating the status (healthy or T2D) and the second the sex of the samples. Bonferroni adjustment was used for the multiple comparison correction and the Benjamini-Hochberg method to control the false discovery rate at significance level α=0.01. The genes that showed significant differences in respect to sex were excluded from the results in both tests in order to identify the differentially expressed genes related to T2D. The two tests yielded overlapping results, but the gene sets obtained from the non-parametric design were less affected by the non-normal distributions of gene expression, reflecting more robust disease related differences. Therefore, we report and use in the downstream analysis the results provided by the non-parametric test. In the case of δ-cells, both tests reported no significant results due to the existence of a group with a very small sample size (healthy female group consisting of only two cells). To overcome this limitation, we performed one-way Analysis of variance (parametric and non-parametric) using only the cells from the male donors, but no interesting genes were reported (SNORD110 and COL6A2). The differentially expressed genes between the healthy and T2D cells for each cell type are listed in Table S6 .
Gene set enrichment analysis in cell types
Gene set enrichment analysis (GSEA) was used to examine whether the genes identified as differentially expressed between the healthy and T2D cells for each cell type are members of categories with specific functions. We used the pre-ranked version, providing the difference in median expression values between the healthy and T2D cells as the gene ranking metric. For each cell type, the ranked list of genes was tested for overlaps with all the gene sets belonging to four major collections of the Molecular Signatures Database: curated gene sets (C2), GO gene sets (C5), oncogenic signatures (C6) and immunologic signatures (C7). The significant categories (FDR≤1%) that are enriched in each cell type for the two conditions are reported in Table S7 .
